Math Over Myth: These Psychedelic Stocks Made Confirmed Bottoms in Q3
Math over Myth is your weekly update on psychedelic stocks and ETFs, including ATAI, COMPASS, Cybin, GH Research, Mindset, Numinus, and more
numinus
Math Over Myth: Weekly Psychedelic Stocks News Roundup
Get the latest news on psychedelic stocks Cybin, Numinus, MindMed, ATAI, Mindset, Braxia, Tryp, Irwin Naturals, and Revive
End of Life: Psychedelics in Palliative Care
We interview Dr. Paul Thielking, Chief Science Officer of Numinus, about the use of psychedelics in palliative care and end of life care
This Week in Psychedelic Stocks: Compass Pathways Wins Patent Battle, MindMed Patents Candy Flipping, and More!
This week in psychedelic stock news, there are big patent developments for Compass, MindMed and Numinus.
End of content
End of content